<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink">
  <front>
    <journal-meta />
    <article-meta>
      <title-group>
        <article-title>Protein Signaling Pathway: Network Centrality Analysis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <string-name>Inva Koçiaj</string-name>
          <email>inva.kociaj@gmail.com</email>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Eliana Ibrahimi</string-name>
          <email>eliana.ibrahimi@fshn.edu.al</email>
          <xref ref-type="aff" rid="aff0">0</xref>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Dode Prenga</string-name>
          <email>dode.prenga@fshn.edu.al</email>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <aff id="aff0">
          <label>0</label>
          <institution>University of Tirana, Faculty of Natural Sciences, Department of Biology</institution>
          ,
          <addr-line>Tirana, 1001</addr-line>
          ,
          <country country="AL">Albania</country>
        </aff>
        <aff id="aff1">
          <label>1</label>
          <institution>University of Tirana, Faculty of Natural Sciences, Department of Physics</institution>
          ,
          <addr-line>Tirana, 1001</addr-line>
          ,
          <country country="AL">Albania</country>
        </aff>
      </contrib-group>
      <abstract>
        <p>The topology of a biological network may differ, depending on the type of elements and the interactions between them. A protein signaling pathway considered as a directed network can be studied through the centralities analysis. The knowledge about the centralities is crucial to determine the most important network nodes, which can somehow define the further analysis needed for that network. Here we make a structural analysis of two networks, the AMPK-signaling pathway, and the mTOR-signaling pathway. The commonalities between these two networks are visible, and calculation of the centralities for all the nodes of the two networks show that they both have the same most important nodes, meaning that the signal inside the networks passes mostly through the same most important proteins such as AMPK, mTOR, RHEB, Akt, ELK1.2, and TSC1/2. However, we aim to go beyond this process. Our purpose is to make a dynamic study of a new bigger network composed of the most important nodes of these two elementary nodes. In this way, we can better predict all these vital proteins' effects on other elements, inside or outside the network.</p>
      </abstract>
      <kwd-group>
        <kwd>Network</kwd>
        <kwd>AMPK-mTOR Pathways</kwd>
        <kwd>Topology</kwd>
        <kwd>Analysis</kwd>
        <kwd>Centrality</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec-1">
      <title>1. Introduction</title>
      <p>
        Knowledge about the topology of any
network is very important not only for
understanding how its elements are arranged
but also to know the relations between them.
As there are different types of networks, there
exist different types of network topologies,
and to determine the right one, network
analysis is required. This analysis corresponds
to the graph theory application, according to
which the network components are modeled as
nodes and the connections between them are
modeled as edges that show the type of
relationships that exist between these nodes
[
        <xref ref-type="bibr" rid="ref18">1</xref>
        ]. Thus, the graph corresponding to a
specific system (network) is a set of vertices
(nodes) and a set of edges (links) that connect
a pair of nodes.
      </p>
      <p>2021 Copyright for this paper by its authors. Use permitted under Creative
Commons License Attribution 4.0 International (CC BY 4.0).</p>
      <p>CEUR Workshop Proceedings (CEUR-WS.org)</p>
      <p>Different networks such as computer
networks, social networks, and disease
networks have been studied for years, while
biological systems have only been studied for
a few years from now. Theoretical methods
used for this purpose have continuously
increased the interest among scientists to
investigate more about the topology of a
biological network and not only.</p>
      <p>
        Biological systems can be introduced by
undirected graphs, directed graphs, or
weighted graphs. In each case, nodes represent
genes, proteins, enzymes, or other metabolic
and transcription elements, whereas links
represent several interactions such as physical
interactions, signaling pathways,
coexpression, activation, and inhibition. Here,
we present a study of the structure analysis of
two signaling pathways; AMP-activated
protein kinase (AMPK) signaling pathway,
and target of mammalian rapamycin (mTOR)
signaling pathway, both created and presented
by SIGNOR [
        <xref ref-type="bibr" rid="ref1 ref2">2</xref>
        ]. We make the structural
analysis of these two different protein
signaling pathways by using Cytoscape [3].
We analyze both networks' centralities,
compare them to each other, and go further
with the analysis. For all elements, in both
networks, we observe all centralities with the
purpose to find out which are the most
important elements. Two protein kinases, such
as AMPK and mTOR, are on the focus of both
signaling pathway networks, and interestingly
it is noticed that in both of them, the biological
signal is mostly transmitted through the same
elements (proteins). In these circumstances,
our purpose is not only to show the network
analysis but what is more important is that we
aim to prove that the role and the importance
of these common proteins, found in these two
networks, are the same in both of them. We
believe that this outcome enables us to build a
new bigger network, composed of all these
examined nodes, and that can help us look for
further answers. Continuing further, it is
important to emphasize that despite the
differences that result in the outputs of these
two signaling pathways, there are also some
bond connections between them because of the
biochemical processes that they represent. For
this reason, we believe that all of these
outputs, presented also as phenotypes of the
biological systems, can be considered for the
new aimed network, that we want to proceed
with, in the upcoming research work.
      </p>
    </sec>
    <sec id="sec-2">
      <title>2. Background: AMPK and mTOR signaling Pathways</title>
      <p>Cell growth is regulated by maintaining the
balance between the positive regulation of
anabolic pathways and the negative regulation
of catabolic pathways. The mTOR and AMPK
signaling pathways regulate growth and
metabolism, with mTOR activating the
anabolic processes and AMPK inducing a
catabolic response when cells have low energy
levels [4]. In this section, we give brief
information on these two kinases and their role
in breast cancer and the regulation of cell
growth.</p>
      <p>AMP-activated protein kinase regulates cell
energy homeostasis. AMPK is activated when
there is a fall in ATP level, resulting in the
activation of catabolic processes and the
inhibition of anabolic processes [3, 4]. This
crucial metabolic sensor regulates protein and
lipid metabolism based on the alterations of
energy levels.</p>
      <p>In the past decade, more studies have
focused on AMPK since it appeared to be a
targeting molecule for cancer therapy. Many
research studies have focused on
understanding the role of AMPK signaling
pathways in the regulation of growth and the
development of drug resistance in
triplenegative breast cancer [5].</p>
      <p>Expression of AMPK is correlated with
breast cancer stage and distant metastasis,
patients with positive expression of AMPK
exhibit shorter overall survival and
diseasefree survival [6]. These results suggest AMPK
as a possible prognostic biomarker for
triplenegative breast cancer. Recent research has
reported that AMPK is reduced by 90% in
cancer tissues of primary breast cancer patients
than normal breast epithelial cells [7]
Decreased AMPK signaling and the negative
correlation with cancer grade/metastasis shows
that AMPK reactivation can prevent breast
cancer [5].</p>
      <p>
        The mTOR complex is part of the
PI3Krelated protein kinase family, and it is located
on chromosome 1p36.2 [8, 9]. Several studies
have reported that rapamycin is involved in
antitumor activities and can inhibit cell
division [
        <xref ref-type="bibr" rid="ref41 ref8">10</xref>
        ]. It has two protein complexes,
mTORC1 and mTORC2, that have differences
in elements and functions [11, 12, 13].
      </p>
      <p>mTOR has an important role in gene
transcription, protein translation, ribosome
synthesis, and a fundamental regulatory role in
cell growth, cell division, differentiation, and
apoptosis [14]. It is also reported that mTOR
has an important role in tumor growth and
metabolism, and plays a crucial role in breast
cancer. The protein components of the mTOR
are encoded by oncogenes or tumor suppressor
genes. The mTOR pathway depends on the
activation or the inhibition of the pathway
signaling. In breast cancer, activation of the
mTOR pathway is evaluated to be as common
as 70% of breast cancer overall [15].</p>
    </sec>
    <sec id="sec-3">
      <title>3. Experimental Setup</title>
      <p>
        Here, we work on two signaling pathway
networks, firstly generated and presented from
SIGNOR [
        <xref ref-type="bibr" rid="ref1 ref2">2</xref>
        ], and then imported and
represented for further analysis in Cytoscape
(Figure 1) [16]. Cytoscape is an open-source
platform, for general-purpose modeling, that is
used to visualize and analyze molecular
interaction networks and signaling pathways
of large-scale complex networks (especially
biological systems).
      </p>
      <p>Cytoscape’s Core is J-abvaased that
provides basic functionalities for integrating
arbitrary data of different formats, imported
from several sources. As previously
mentioned, the two networks on focus here,
are directly imported into Cytoscape, whose
data were downloaded sinbm“l” format from a
public database such as SIGNOR.</p>
      <p>This is realized via NDE-x project (The
Network Data Exchange) which provides to
the researchers an open-source framework to
store, modify, share, etc their networks.
Because of its features, the networks were
directly imported to Cytoscape without having
the necessity of processing their data before.
Furthermore, as we focus on centralities, the
analysis of these networks was performed by
running CentiScaPe2.2 (Figure 2 and
Appendix), which is one of the Apps,
incorporated into Cytoscape. As we firstly
make a simple network analysis, we can see
the networks’ general characteristiscusch as
the number of nodes, the number of edges,
diameter, network radius, etc., that allows us
to make a quick comparison between them
(See Appendix).</p>
      <p>Continuing further, a deeply structural analysis
is made (for both networks), and the path
followed toward the understanding of the most
important nodes of the networks is through the
analysis of the centralities for each element,
such as diameter, average path, in-degree, and
out-degree, eccentricity, radiality, closeness,
stress, betweenness, centroid, eigenvector and
bridging parameter [3, 17].</p>
    </sec>
    <sec id="sec-4">
      <title>4. Results and Discussion</title>
      <p>The evaluation of the centralities for each
node of the network gives us a better
understanding of its functionalities. Structural
analysis through Cytoscape is based on several
algorithms related to those hidden data that a
simple general view of the network cannot
find out [17, 19]. As running the
CentiScaPe2.2 package, we reach the results
about the centralities we are interested in and
find out that there are some differences
between the two networks, and there are also
many other commonalities between them.</p>
      <p>While network diameter and average path
are two parameters that are more reliable for
big networks, other centrality parameters can
give important and reliable information
applied even for small networks as our
networks are. Thus, we analyze the results
performed to see if the same elements have the
same importance or not. Since both signaling
pathways are directed networks, we can easily
notice the interaction between nodes.
According to the function that each node has
(activation or inhibition) and the number of
interactions it has with other nodes, we can
pre-predict the most important nodes of the
networks.</p>
      <p>Generally speaking, these centralities are
used to determine not only the importance of
the network but also the importance of each
node found in the network. However, it is
recommended that to define the importance of
each node it is a necessity to compare several
centralities simultaneously. In this way, we get
more accurate information, and consequently,
we can remove the less important nodes from
the network without losing any important
information [17].</p>
      <p>Figure 2 shows the values of those general
centrality parameters that are related to the
networks, not a specific node, but on the other
hand, obviously are different. Despite these
differences, our analysis includes all general
centralities, and the information we achieve
from this is as follows:</p>
      <p>The degree is a parameter determined as
in-degree and out-degree and shows the
number of the directed links connecting two
nodes. While in-degree shows the links
entering a node, out-degree shows the number
of links going out from the target node. The
nodes characterized by a high value of degree
are considered central nodes as they play a key
role in transmitting the signal in the network
[18]. The central nodes seem to be the same
elements in both networks, such as AMPK,
mTOR, EIF4EBP1, INSR, ERK1/2.</p>
      <p>Stress is another very important parameter
that shows the importance of a node compared
to another one. A stressed node is considered
the one which is mostly reached from other
nodes following the shortest paths. A stressed
node can be an important node in a signaling
pathway network that connects all other
regulatory nodes, but it can be even a very
involved node in cells’ processes [17]., So1,9
from our observations, we realize that the most
stressed common nodes are: IRS1, mTOR,
RHEB, TSC1/2, PDPK1, Akt, PIK3CA, and
phosphate group.</p>
      <p>Betweenness and Centroid are two
centralities that are strongly related to stress
centrality [20]. They are complementary to
each other that together give a better
understanding of the required information.
Nevertheless, a high value of the betweenness
parameter is mostly related to a protein that
keeps together the other communicated
proteins of the network. In contrast, a node
with a high value of centroid (higher than the
average value of the network) is considered
very important. It represents a protein involved
in the coordination of other proteins’ activities,
leading to the participation in a cell regulatory
activity. Proteins highlighted here for both
networks are AMPK, mTOR, RHEB, TSC1/2,
Akt, ULK1, RPS6KB1.</p>
      <p>
        Eigenvector Centrality is a parameter that
shows the importance of a node based on the
assumption that high-scored nodes perform
better than low-scored ones. According to this
parameter, the importance of a specific node is
determined not only by the number of its first
neighbors connected to it but also from the
value of the Eigenvector of each of these first
neighbors [
        <xref ref-type="bibr" rid="ref9">21</xref>
        ]. In the biological meaning, this
refers to a protein that interacts with several
regulatory proteins simultaneously. Such a
protein is considered a central node of the
network, and the bigger the Eigenvector value
is, the more this protein can generate other
biological effects in the network. According to
this parameter, the nodes in both networks that
seem to be more important are ERK1/2,
ULK1, AMPK, mTOR.
      </p>
      <p>Bridging Centrality is another parameter
that is different in both signaling pathway
networks. This parameter indicates the ability
of a node to position itself as a connecting
bridge between two other nodes [18]. The
bridging centrality parameter is bigger if a
high degree parameter characterizes the nodes
connected to the bridge node, and the proteins
highlighted here are RHEB, PIK3CA, TSC1/2,
ULK1.</p>
      <p>It is very imortant to emphasize that all
average values of all centralities are
considered meaningful only when they are
compared to the minimum and the maximum
values that correspond to the nodes
characterized by these values [20].
40
20
0
400
300
200
100</p>
      <p>0
60
40
20
0
-20
-40</p>
      <sec id="sec-4-1">
        <title>Out-Degree &amp; In-Degree</title>
        <p>Minimum</p>
        <p>Maximum</p>
        <p>Average
AMPK: Out-Degree AMPK: In-Degree
mTOR: Out-Degree mTOR: In-Degree</p>
      </sec>
      <sec id="sec-4-2">
        <title>Betweenness Centrality</title>
        <p>181
312
267057</p>
      </sec>
    </sec>
    <sec id="sec-5">
      <title>5. Conclusions and Future Work</title>
      <p>The structure analysis realized through
Cytoscape was made to define the most
important nodes of the network, and this
procedure is made for two different signaling
pathway networks, such as the
AMPKsignaling pathway and mTOR-signaling
pathway. Both networks are characterized by
direct connections between proteins whose
signaling pathways are two protein kinases,
AMPK, and mTOR. The relation between
these two proteins is very strong, and usually,
they are found together in most of the proteins'
networks. Even here, we see many elements
found in both networks and not only that, but
we see that their function toward other
proteins is the same. To show the
commonalities between networks, we analyze
all the centralities via structural analysis. It is
found that some of the centralities such as
eccentricity, radiality, closeness give almost
the same values for both networks, whereas
some other centralities such as in/out-degree,
stress, betweenness, centroid, Eigenvector, and
bridging parameter show different values in
both networks. Nevertheless, the fact that these
networks are almost composed of the same
elements, the differences between them are not
so big. Moreover, since that mTOR-signaling
pathway network has more elements inside it,
it justifies these differences.</p>
      <p>The network is better described if all these
centralities are analyzed for each node of the
network separately. To determine which the
most important nodes are, we should pay the
same attention to all these centralities at the
same time. From this analysis, we define
several nodes that are considered the most
important ones, and interestingly some nodes
are highlighted in almost all these centralities.
Thus, we suggest that all those proteins
highlighted from the analysis of the centralities
are the most important nodes of the network.
Even more interesting is the fact that we find
the same most important proteins in both
networks, giving us the permission to
marginalize both networks and build a new
one composed of the most important
nodes/proteins so that the new network can be
powerful in transmitting the signaling.
Our ongoing future work is the study of the
biological network's dynamical evolution. The
dynamical analysis, this time will be based on
Boolean modeling, whose logical functions
will be written only for the most important
nodes of the network determined by this
structure analysis.</p>
    </sec>
    <sec id="sec-6">
      <title>6. References</title>
      <p>
        [
        <xref ref-type="bibr" rid="ref18">1</xref>
        ] T. J. Grant, R. H. P. Janssen, and H.
      </p>
      <p>
        Monsuur, Network Topology in Command
and Control: Organization, Operation and
Evolution. 1st edition, IGI Global, US,
(2014).
[
        <xref ref-type="bibr" rid="ref1 ref2">2</xref>
        ] L. Licata, P. L. Surdo, M. Iannuccelli, A.
      </p>
      <p>Palma, E. Micarelli, L. Perfetto, D. Peluso,
General characteristics of both networks generated by Cytoscape</p>
      <p>The centralities for the most important nodes, in both networks, are given below. The left side
corresponds to the nodes' analysis AMPK-signaling pathway network whereas the right side
corresponds to the nodes' analysis in the mTOR-signaling pathway.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="ref1">
        <mixed-citation>
          <source>SIGNOR 2</source>
          .0, the Signaling Network Open
        </mixed-citation>
      </ref>
      <ref id="ref2">
        <mixed-citation>
          <source>Resource 2.0: 2019 update, J. Nucleic</source>
        </mixed-citation>
      </ref>
      <ref id="ref3">
        <mixed-citation>
          <source>Acids Research</source>
          ,
          <volume>48</volume>
          , (
          <year>2020</year>
          ),
          <fpage>504</fpage>
          -
          <lpage>510</lpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref4">
        <mixed-citation>
          https://doi.org/10.1093/nar/gkz949 [3]
          <string-name>
            <given-names>M.</given-names>
            <surname>Cline</surname>
          </string-name>
          ,
          <string-name>
            <given-names>M.</given-names>
            <surname>Smoot</surname>
          </string-name>
          , E. Cerami.
        </mixed-citation>
      </ref>
      <ref id="ref5">
        <mixed-citation>
          <source>Nat Protoc</source>
          <volume>2</volume>
          (
          <year>2007</year>
          )
          <fpage>2366</fpage>
          -
          <lpage>2382</lpage>
        </mixed-citation>
      </ref>
      <ref id="ref6">
        <mixed-citation>
          https://doi.org/10.1038/nprot.
          <year>2007</year>
          .
          <volume>324</volume>
          [4]
          <string-name>
            <given-names>SK.</given-names>
            <surname>Hindupur</surname>
          </string-name>
          ,
          <string-name>
            <given-names>A.</given-names>
            <surname>González</surname>
          </string-name>
          , MN. Hall.
        </mixed-citation>
      </ref>
      <ref id="ref7">
        <mixed-citation>
          <source>Harb Perspect Biol</source>
          <volume>3</volume>
          . (
          <year>2015</year>
          )
          <volume>7</volume>
          (
          <issue>8</issue>
          ). doi:
        </mixed-citation>
      </ref>
      <ref id="ref8">
        <mixed-citation>
          10.1101/cshperspect.a019141. [5]
          <string-name>
            <given-names>W.</given-names>
            <surname>Cao</surname>
          </string-name>
          ,
          <string-name>
            <given-names>J.</given-names>
            <surname>Li</surname>
          </string-name>
          ,
          <string-name>
            <given-names>Q.</given-names>
            <surname>Hao</surname>
          </string-name>
          , J V. Vadgama Y.
        </mixed-citation>
      </ref>
      <ref id="ref9">
        <mixed-citation>
          21, (
          <year>2019</year>
          )
          <article-title>29</article-title>
          . https://doi.org/10.1186/s13058-
        </mixed-citation>
      </ref>
      <ref id="ref10">
        <mixed-citation>
          019-
          <fpage>1107</fpage>
          -
          <issue>2</issue>
          [6]
          <string-name>
            <given-names>X.</given-names>
            <surname>Huang</surname>
          </string-name>
          ,
          <string-name>
            <given-names>X.</given-names>
            <surname>Li</surname>
          </string-name>
          ,
          <string-name>
            <given-names>X.</given-names>
            <surname>Xie</surname>
          </string-name>
          ,
          <string-name>
            <given-names>F.</given-names>
            <surname>Ye</surname>
          </string-name>
          ,
          <string-name>
            <given-names>B.</given-names>
            <surname>Chen</surname>
          </string-name>
          ,
        </mixed-citation>
      </ref>
      <ref id="ref11">
        <mixed-citation>
          <article-title>biomarkers for breast cancer</article-title>
          .
          <source>Breast.,30</source>
        </mixed-citation>
      </ref>
      <ref id="ref12">
        <mixed-citation>
          (
          <year>2016</year>
          )
          <fpage>39</fpage>
          -
          <lpage>46</lpage>
          . [7]
          <string-name>
            <given-names>SM.</given-names>
            <surname>Hadad</surname>
          </string-name>
          , L. Baker, PR. Quinlan, KE.
        </mixed-citation>
      </ref>
      <ref id="ref13">
        <mixed-citation>
          <string-name>
            <surname>Cancer.</surname>
          </string-name>
          (
          <year>2009</year>
          )
          <volume>9</volume>
          :
          <fpage>307</fpage>
          . [8]
          <string-name>
            <given-names>N.D.</given-names>
            <surname>Golberg</surname>
          </string-name>
          ,
          <string-name>
            <given-names>A.M.</given-names>
            <surname>Druzhevskaya</surname>
          </string-name>
          , V.A.
        </mixed-citation>
      </ref>
      <ref id="ref14">
        <mixed-citation>
          Physiol.,
          <volume>40</volume>
          (
          <year>2014</year>
          ).
          <fpage>580</fpage>
          -
          <issue>588</issue>
          [9]
          <string-name>
            <given-names>G.J.</given-names>
            <surname>Wiederrecht</surname>
          </string-name>
          ,
          <string-name>
            <given-names>C.J.</given-names>
            <surname>Sabers</surname>
          </string-name>
          ,
          <string-name>
            <given-names>G.J.</given-names>
            <surname>Brunn</surname>
          </string-name>
          ,
        </mixed-citation>
      </ref>
      <ref id="ref15">
        <mixed-citation>
          <article-title>insights into the regulation of G1-phase</article-title>
        </mixed-citation>
      </ref>
      <ref id="ref16">
        <mixed-citation>
          <string-name>
            <given-names>Cycle</given-names>
            <surname>Res</surname>
          </string-name>
          .,
          <volume>1</volume>
          (
          <year>1995</year>
          ),
          <fpage>53</fpage>
          -
          <lpage>71</lpage>
          . [10]
          <string-name>
            <given-names>W.M.</given-names>
            <surname>Flanagan</surname>
          </string-name>
          , G.R. Crabtree
        </mixed-citation>
      </ref>
      <ref id="ref17">
        <mixed-citation>
          <source>Rapamycin inhibits p34cdc2 expression</source>
        </mixed-citation>
      </ref>
      <ref id="ref18">
        <mixed-citation>
          <article-title>the G1/S transition Ann</article-title>
          . Ny. Acad.
        </mixed-citation>
      </ref>
      <ref id="ref19">
        <mixed-citation>
          Sci.,
          <volume>696</volume>
          (
          <year>2006</year>
          ),
          <fpage>31</fpage>
          -
          <lpage>36</lpage>
          . [11]
          <string-name>
            <given-names>D.</given-names>
            <surname>Sarbassov</surname>
          </string-name>
          ,
          <string-name>
            <given-names>S.M.</given-names>
            <surname>Ali</surname>
          </string-name>
          ,
          <string-name>
            <given-names>D.H.</given-names>
            <surname>Kim</surname>
          </string-name>
          ,
          <string-name>
            <surname>D.A.</surname>
          </string-name>
        </mixed-citation>
      </ref>
      <ref id="ref20">
        <mixed-citation>
          <source>cytoskeleton Curr. Biol</source>
          .,
          <volume>14</volume>
          (
          <year>2004</year>
          ),
          <fpage>1296</fpage>
          -
        </mixed-citation>
      </ref>
      <ref id="ref21">
        <mixed-citation>
          1302. [12]
          <string-name>
            <given-names>R.</given-names>
            <surname>Peterson</surname>
          </string-name>
          ,
          <string-name>
            <given-names>M.</given-names>
            <surname>Laplante</surname>
          </string-name>
          ,
          <string-name>
            <given-names>C.C.</given-names>
            <surname>Thoreen</surname>
          </string-name>
          ,
        </mixed-citation>
      </ref>
      <ref id="ref22">
        <mixed-citation>
          <source>their survival Cell</source>
          ,
          <volume>137</volume>
          (
          <year>2009</year>
          ),
          <fpage>873</fpage>
          -
          <lpage>886</lpage>
          . [13]
          <string-name>
            <given-names>D.</given-names>
            <surname>Gao</surname>
          </string-name>
          ,
          <string-name>
            <given-names>L.</given-names>
            <surname>Wan</surname>
          </string-name>
          ,
          <string-name>
            <given-names>H.</given-names>
            <surname>Inuzuka</surname>
          </string-name>
          ,
          <string-name>
            <given-names>A.H.</given-names>
            <surname>Berg</surname>
          </string-name>
          ,
        </mixed-citation>
      </ref>
      <ref id="ref23">
        <mixed-citation>
          <article-title>Wei Rictor forms a complex with cullin-1</article-title>
        </mixed-citation>
      </ref>
      <ref id="ref24">
        <mixed-citation>
          <article-title>to promote SGK1 ubiquitination and</article-title>
        </mixed-citation>
      </ref>
      <ref id="ref25">
        <mixed-citation>
          <source>destruction Mol. Cell.</source>
          ,
          <volume>39</volume>
          (
          <year>2010</year>
          ),
          <fpage>797</fpage>
          -
        </mixed-citation>
      </ref>
      <ref id="ref26">
        <mixed-citation>
          808. [14]
          <string-name>
            <given-names>T.</given-names>
            <surname>Xu</surname>
          </string-name>
          ,
          <string-name>
            <given-names>D.</given-names>
            <surname>Sun</surname>
          </string-name>
          ,
          <string-name>
            <given-names>Y.</given-names>
            <surname>Chen</surname>
          </string-name>
          , L. Ouyang,
        </mixed-citation>
      </ref>
      <ref id="ref27">
        <mixed-citation>
          https://doi.org/10.1016/j.ejmech.
          <year>2020</year>
          .112
        </mixed-citation>
      </ref>
      <ref id="ref28">
        <mixed-citation>
          391. [15]
          <string-name>
            <surname>QB</surname>
            . She, SK. Gruvberger-Saal,
            <given-names>M.</given-names>
          </string-name>
        </mixed-citation>
      </ref>
      <ref id="ref29">
        <mixed-citation>
          <article-title>therapy targeting PTEN/PI3K</article-title>
          and EGFR
        </mixed-citation>
      </ref>
      <ref id="ref30">
        <mixed-citation>
          <source>BMC Cancer</source>
          <volume>16</volume>
          (
          <issue>1</issue>
          ), (
          <year>2016</year>
          ),
          <fpage>587</fpage>
          . [16]
          <string-name>
            <given-names>P.</given-names>
            <surname>Shannon</surname>
          </string-name>
          ,
          <string-name>
            <given-names>A.</given-names>
            <surname>Markiel</surname>
          </string-name>
          ,
          <string-name>
            <given-names>O.</given-names>
            <surname>Ozier</surname>
          </string-name>
          , NS.
        </mixed-citation>
      </ref>
      <ref id="ref31">
        <mixed-citation>
          <string-name>
            <surname>networks</surname>
          </string-name>
          .
          <source>Genome Res</source>
          ,
          <volume>13</volume>
          :
          <volume>11</volume>
          (
          <fpage>2498</fpage>
          -
          <lpage>504</lpage>
          ).
        </mixed-citation>
      </ref>
      <ref id="ref32">
        <mixed-citation>
          <source>2003 Nov. PubMed ID: 14597658. [17] SP. Borgatti. "Centrality and Network</source>
        </mixed-citation>
      </ref>
      <ref id="ref33">
        <mixed-citation>
          <article-title>Flow"</article-title>
          .
          <source>Social Networks</source>
          . (
          <year>2005</year>
          ),
          <volume>27</volume>
          :
          <fpage>55</fpage>
          -
        </mixed-citation>
      </ref>
      <ref id="ref34">
        <mixed-citation>
          71. doi:
          <volume>10</volume>
          .1016/j.socnet.
          <year>2004</year>
          .
          <volume>11</volume>
          .
          <volume>008</volume>
          [18]
          <string-name>
            <given-names>M.E.J.</given-names>
            <surname>Newman</surname>
          </string-name>
          .
          <source>Networks: An</source>
        </mixed-citation>
      </ref>
      <ref id="ref35">
        <mixed-citation>
          <string-name>
            <surname>Introduction.</surname>
          </string-name>
          (
          <year>2010</year>
          ) Oxford, UK: Oxford
        </mixed-citation>
      </ref>
      <ref id="ref36">
        <mixed-citation>
          University Press. [19]
          <string-name>
            <given-names>A. R.</given-names>
            <surname>Mashaghi</surname>
          </string-name>
          ,
          <string-name>
            <given-names>A.</given-names>
            <surname>Ramezanpour</surname>
          </string-name>
          , and V.
        </mixed-citation>
      </ref>
      <ref id="ref37">
        <mixed-citation>
          <source>Systems 41.1</source>
          (
          <year>2004</year>
          ):
          <fpage>113</fpage>
          -
          <lpage>121</lpage>
          . [20]
          <string-name>
            <given-names>G.</given-names>
            <surname>Scardoni</surname>
          </string-name>
          , and
          <string-name>
            <given-names>C.</given-names>
            <surname>Laudanna</surname>
          </string-name>
          .
        </mixed-citation>
      </ref>
      <ref id="ref38">
        <mixed-citation>
          <string-name>
            <surname>Theory</surname>
          </string-name>
          (
          <year>2012</year>
          ):
          <fpage>323</fpage>
          -
          <lpage>348</lpage>
          . [21]
          <string-name>
            <given-names>N.F.A.</given-names>
            <surname>Christian</surname>
          </string-name>
          ,
          <string-name>
            <given-names>N.M.</given-names>
            <surname>Uriel</surname>
          </string-name>
          ,
          <string-name>
            <given-names>P.H.</given-names>
            <surname>Heidi</surname>
          </string-name>
          ,
        </mixed-citation>
      </ref>
      <ref id="ref39">
        <mixed-citation>
          <source>Academy of Sciences</source>
          .
          <volume>115</volume>
          (
          <issue>52</issue>
          ) (
          <year>2018</year>
          ),
        </mixed-citation>
      </ref>
      <ref id="ref40">
        <mixed-citation>
          <string-name>
            <surname>E12201- E12208.</surname>
          </string-name>
        </mixed-citation>
      </ref>
      <ref id="ref41">
        <mixed-citation>
          <source>doi:10</source>
          .1073/pnas.1810452115.
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>